Caspase- and serine protease-dependent apoptosis by the death domain of fadd in normal epithelial cells

Molecular Biology of the Cell

Volumn 14, Issue 1, 2003, Pages 67-77

  Thorburn, Jacqueline ^a   Bender, Laura M ^a   Morgan, Michael J ^a   Thorburn, Andrew ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CASPASE; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 9; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; SERINE PROTEINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL DEATH; CELL KILLING; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOVIRIDAE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; CASPASES; EPITHELIUM; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; PROSTATE; PROTEIN STRUCTURE, TERTIARY; SERINE ENDOPEPTIDASES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037237988     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E02-04-0207     Document Type: Article

References (49)

1. Ashkenazi, A., and Dixit, V.M. (1998). Death receptors: signaling and modulation. Science 281, 1305-1308.
2. Ashkenazi, A. et al. (1999). Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104, 155-162.
3. Bantel, H., Ruck, P., and Schulze-Osthoff, K. (2000). In situ monitoring of caspase activation in hepatobiliary diseases. Cell Death Differ. 7, 504-505.
4. Caulin, C., Salvesen, G.S., and Oshima, R.G. (1997). Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell Biol. 138, 1379-1394.
5. Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
6. Coleman, M.L., Sahai, E.A., Yeo, M., Bosch, M., Dewar, A., and Olson, M.F. (2001). Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3, 339-345.
7. Denecker, G. et al. (2001). Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ. 8, 829-840.
8. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. (2000). Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42.
9. Elliott, K., Ge, K., Du, W., and Prendergast, G.C. (2000). The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Oncogene 19, 4669-4684.
10. Foghsgaard, L., Wissing, D., Mauch, D., Lademann, U., Bastholm, L., Boes, M., Elling, F., Leist, M., and Jaattela, M. (2001). Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153, 999-1010.
11. Goldstein, J.C., Waterhouse, N.J., Juin, P., Evan, G.I., and Green, D.R. (2000). The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat. Cell Biol. 2, 156-162.
12. Green, D.R., and Evan, G.I. (2002). A matter of life and death. Cancer Cell 1, 19-30.
13. Guicciardi, M.E., Deussing, J., Miyoshi, H., Bronk, S.F., Svingen, P.A., Peters, C., Kaufmann, S.H., and Gores, G.J. (2000). Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106, 1127-1137.
14. Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70.
15. Hegde, R. et al. (2002). Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts IAP-caspase interaction. J. Biol. Chem. 277, 432-438.
16. Hengartner, M.O. (2000). The biochemistry of apoptosis. Nature 407, 770-776.
17. Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81, 495-504.
18. Johnson, D.E. (2000). Noncaspase proteases in apoptosis. Leukemia 14, 1695-1703.
19. Jones, B., Roberts, P.J., Faubion, W.A., Kominami, E., and Gores, G.J. (1998). Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am. J. Physiol. 275, G723-G730.
20. Leist, M., and Jaattela, M. (2001a). Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell. Biol. 2, 589-598.
21. Leist, M., and Jaattela, M. (2001b). Triggering of apoptosis by cathepsins. Cell Death Differ. 8, 324-326.
22. Li, H. et al. (2000). Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289, 1159-1164.
23. Li, L.Y., Luo, X., and Wang, X. (2001). Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412, 95-99.
24. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S., and Wang, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
25. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. (1998). Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490.
26. Martins, L.M. et al. (2002). The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a Reaper-like motif. J. Biol. Chem. 277, 439-444.
27. McCarthy, N.J., Whyte, M.K., Gilbert, C.S., and Evan, G.I. (1997). Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136, 215-227.
28. Morgan, M.J., and Thorburn, A. (2001). Measurement of caspase activity in individual cells reveals differences in the kinetics of caspase activation between cells. Cell Death Differ. 8, 38-43.
29. Morgan, M.J., Thorburn, J., Thomas, L., Maxwell, T., Brothman, A.R., and Thorburn, A. (2001). An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells. Cell Death Differ. 8, 696-705.
30. Nesterov, A., Ivashchenko, Y., and Kraft, A.S. (2002). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene 21, 1135-1140.
31. Nicholson, D.W. (1999). Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6, 1028-1042.
32. Pinkoski, M.J., Waterhouse, N.J., Heibein, J.A., Wolf, B.B., Kuwana, T., Goldstein, J.C., Newmeyer, D.D., Bleackley, R.C., and Green, D.R. (2001). Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway. J. Biol. Chem. 276, 12060-12067.
33. Renatus, M., Stennicke, H.R., Scott, F.L., Liddington, R.C., and Salvesen, G.S. (2001). Dimer formation drives the activation of the cell death protease caspase 9. Proc. Natl. Acad. Sci. USA 98, 14250-14255.
34. Rokhlin, O.W., Glover, R.A., and Cohen, M.B. (1998). Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7. Cancer Res. 58, 5870-5875.
35. Salvesen, G.S., and Dixit, V.M. (1999). Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA 96, 10964-10967.
36. Schotte, P., Declercq, W., Van Huffel, S., Vandenabeele, P., and Beyaert, R. (1999). Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 442, 117-121.
37. Sebbagh, M., Renvoize, C., Hamelin, J., Riche, N., Bertoglio, J., and Breard, J. (2001). Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell Biol. 3, 346-352.
38. Stoka, V. et al. (2001). Lysosomal protease pathways to apoptosis: cleavage of bid, not Pro-caspases, is the most likely route. J. Biol. Chem. 276, 3149-3157.
39. Susin, S.A. et al. (1999). Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446.
40. Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K., and Takahashi, R. (2001). A serine protease, htra2, is released from the mitochondria and interacts with xiap, inducing cell death. Mol. Cell 8, 613-621.
41. Thomas, L., Stillman, D., and Thorburn, A. (2002). Regulation of FADD death domain interactions by the death effector domain identified by a modified reverse two hybrid screen. J. Biol. Chem. 277, 34343-34348.
42. van Eijk, M., and de Groot, C. (1999). Germinal center B cell apoptosis requires both caspase and cathepsin activity. J. Immunol. 163, 2478-2482.
43. van Loo, G. et al. (2002). The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ. 9, 20-26.
44. Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Van Loo, G., Declercq, W., Grooten, J., Fiers, W., and Vandenabeele, P. (1998a). Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187, 1477-1485.
45. Vercammen, D., Brouckaert, G., Denecker, G., Van de Craen, M., Declercq, W., Fiers, W., and Vandenabeele, P. (1998b). Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188, 919-930.
46. Verhagen, A.M., Ekert, P.G., Pakusch, M., Silke, J., Connolly, L.M., Reid, G.E., Moritz, R.L., Simpson, R.J., and Vaux, D.L. (2000). Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43-53.
47. Verhagen, A.M et al. (2002). HtrA2 promotes cell death through its serine protease activity and its ability to antagonise inhibitor of apoptosis proteins. J. Biol. Chem. 277, 445-454.
48. Wajant, H., Johannes, F.-J., Haas, E., Siemienski, K., Schwenzer, R., Schubert, G., Weiss, T., Grell, M., and Scheurich, P. (1998). Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/ Apo2-mediated cell death but not gene induction. Curr. Biol. 8, 113-116.
49. Walczak, H. et al. (1999). Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5, 157-163.